The possible molecular mediators linking NAFLD and CVD include proatherogenic mediators released from the liver, including C-reactive protein, fibrinogen and plasminogen activator inhibitor-1.33 The gene discussed is SERPINE1; the disease is metabolic dysfunction-associated steatotic liver disease.